Patent application number | Description | Published |
20100027918 | Foil container - A foil container for storing components of a multi-component mass and for being inserted in a receptacle of an ejection device, includes a first foil bag ( | 02-04-2010 |
20110143061 | TWO-COMPONENT ADHESIVE SUITABLE FOR CONSTRUCTION PURPOSES, ITS USE AND THE CURED STRUCTURAL BONDS OBTAINED THEREBY - A two-component adhesive composition suitable for structural bonding of concrete/concrete, steel/concrete, or steel/steel, as well as for structural strengthening and reinforcing applications with fiber reinforced polymers, is disclosed. The composition includes a resin component A with a peroxide containing at least one norbornene group and at least one methacrylate containing compound and a hardener component B comprising a peroxide and at least one thiol. The resin component A and the hardener component B are spatially separated from one another to inhibit any reaction before mixing of the components. | 06-16-2011 |
20110236612 | Chemical two-component mortar compound with improved adhesion to the surface of partially cleaned and/or moist holes in mineral substrates, and the use of such a chemical two-component mortar compound - A chemical two-component mortar compound including a resin component (A) that contains at least one radically curable, ethylenically unsaturated compound (a) as the curable component, and including a separately arranged so as to inhibit reaction curing component (B) that contains a curing agent for the resin of the resin component (A), with improved adhesion to the surface of partially cleaned and/or moist holes in mineral substrates, characterized by a content of 0.2% to 10% by weight of at least one (meth)acryloxy alkyl trialkoxy siloxane and/or poly(meth)acryloxy alkyl silsesquioxane as an additional component (b) of the resin component (A); it also describes magazines, cartridges or plastic bags containing this chemical two-component mortar compound in two or more chambers that are separate from each other, in which the resin component (A) or the curing component (B) are arranged separately so as to inhibit a reaction; and it also describes its use to chemically fasten structural elements in mineral substrates. | 09-29-2011 |
Patent application number | Description | Published |
20150041455 | HEATING ELEMENT - A heating element, in particular a heating element for inductive heating, having an electrically conductive material which can be introduced into a magnetic field, produced by alternating current, of an induction coil, characterized in that the electrically conductive material is divided into a plurality of individual material sections, which are spaced apart from one another in electrically nonconductive fashion and are connected to form a closed conductor network by electrically conductive connecting elements. | 02-12-2015 |
20150060439 | DEVICE FOR INDUCTIVELY HEATING A HEATING ELEMENT - A device and method is provided for inductively heating a heating element, particularly via a magnetic field generated by an induction coil, having an induction coil connected to a resonant circuit, whereby the resonant circuit has at least one first capacitor and at least one first current source, and the coil has a specific inductance and a resistance, and the material of the heating element has a constant permeability at least in temperature subranges, and a method for determining a temperature of a heating element. | 03-05-2015 |
Patent application number | Description | Published |
20090324616 | DIFFERENTIAL CYTOKINE EXPRESSION IN HUMAN CANCER - The invention concerns a method for diagnosing a cancer type, whereby the expression of anti-apoptotic cytokines is determined in the tumour cells. The differential diagnosis of the present invention is used to classify tumour disorders and to recommend the required treatment and to monitor the progress and response to the treatment. | 12-31-2009 |
20100199364 | TNF SUPERFAMILY COLLECTIN FUSION PROTEINS - The present invention refers to a fusion protein comprising a TNF-superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a collectin trimerization domain, to a nucleic acid molecule encoding the fusion protein, and to a cell comprising the nucleic acid molecule. The fusion protein is present as a trimeric complex or as an oligomer thereof. The fusion protein, the nucleic acid, and the cell is suitable as pharmaceutical composition or for therapeutic, diagnostic and/or research applications. | 08-05-2010 |
20110008326 | BINDING AGENTS DIRECTED AGAINST IL-4 RECEPTOR FOR THE TREATMENT OF TUMORS, INFLAMMATORY AND IMMUNOLOGICAL DISORDERS - The present invention relates to the use of an antigen-binding agent directed against human interleukin-4 receptor for the prevention and/or treatment of tumors, inflammatory and immunological disorders. Further the invention relates to methods of inhibiting the bioactivity of IL-4 without inhibiting binding of IL-4 to IL-4R and particularly to methods for treatment and/or prevention of tumors, inflammatory and immunological disorders, the methods comprising administering to an individual in need thereof an antigen-binding agent with binding affinity for IL-4R. | 01-13-2011 |
20110027218 | TNF SUPERFAMILY FUSION PROTEINS - The present invention refers to fusion proteins comprising a TNF superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a trimerization domain and a nucleic acid molecule encoding the fusion protein. The fusion protein is present as a trimeric complex or as an oligomer thereof and is suitable for therapeutic, diagnostic and/or research applications. | 02-03-2011 |
20110162095 | TNFSF Single Chain Molecules - The present invention refers to single-chain fusion proteins comprising three soluble TNF superfamily (TNFSF) cytokine domains and nucleic acid molecules encoding these fusion proteins. The fusion proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications. | 06-30-2011 |
20110224192 | 3-Arylamino Pyridine Derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds | 09-15-2011 |
20120041181 | FUSION PROTEINS FORMING TRIMERS - The present invention refers to fusion proteins comprising a neck region and carbohydrate recognition domain of a collectin trimerization domain, a linker element and an effector polypeptide. Further the invention refers to a nucleic acid encoding the said fusion protein. The fusion proteins, the nucleic acid, and the cell are suitable as pharmaceutical composition or for therapeutic, diagnostic and/or research applications as described herein. | 02-16-2012 |
20120148527 | TNF Superfamily Fusion Proteins - The present invention refers to fusion proteins comprising a TNF superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a trimerization domain and a nucleic acid molecule encoding the fusion protein. The fusion protein is present as a trimeric complex or as an oligomer thereof and is suitable for therapeutic, diagnostic and/or research applications. | 06-14-2012 |
20120295889 | 3-Arylamino Pyridine Derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds | 11-22-2012 |
20130178604 | TNF SUPERFAMILY COLLECTIN FUSION PROTEINS - The present invention refers to a fusion protein comprising a TNF-superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a collectin trimerization domain, to a nucleic acid molecule encoding the fusion protein, and to a cell comprising the nucleic acid molecule. The fusion protein is present as a trimeric complex or as an oligomer thereof. The fusion protein, the nucleic acid, and the cell is suitable as pharmaceutical composition or for therapeutic, diagnostic and/or research applications. | 07-11-2013 |
20140051686 | 3-Arylamino Pyridine Derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds | 02-20-2014 |
20140056843 | TNFSF SINGLE CHAIN MOLECULES - The present invention refers to single-chain fusion proteins comprising three soluble TNF superfamily (TNFSF) cytokine domains and nucleic acid molecules encoding these fusion proteins. The fusion proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications. | 02-27-2014 |
20140171622 | FUSION PROTEINS FORMING TRIMERS - The present invention refers to fusion proteins comprising a neck region and carbohydrate recognition domain of a collectin trimerization domain, a linker element and an effector polypeptide. Further the invention refers to a nucleic acid encoding the said fusion protein. The fusion proteins, the nucleic acid, and the cell are suitable as pharmaceutical composition or for therapeutic, diagnostic and/or research applications as described herein. | 06-19-2014 |
Patent application number | Description | Published |
20120148324 | DEVICE FOR SAMPLING A WEB MOVEMENT, PRINTING SYSTEM AND METHOD FOR CONTROLLING A PROCESSING OPERATION - In a method or device to sample a web movement, an incremental encoder translates the web movement into two phase-offset output signals. A quadrature decoder generates first and second digital output signals with two respective signal levels. The first output signal is designated as a forward signal and the second output signal is designated as a backward signal. An evaluation circuit outputs a control signal and has a first counter that counts a signal change of the forward signal and subtracts from the count a signal change of the backward signal. A second counter counts a signal change of the control signal. A comparator compares values of the first and the second counters. A disabling device enables the forward signal if values of both the first and second counters are the same so that the forward signal is output, and disables the forward signal if values of the two counters are different. | 06-14-2012 |
20130050326 | METHOD FOR ACTIVATING A PROCESSING DEVICE AND PROCESSING DEVICE ACTIVATED IN SUCH A WAY - To activate a processing device which processes a surface of a moving work piece at regular intervals, wherein a predetermined time duration passes between an activation signal of the processing device and the processing on the surface, the movement of the work piece is sensed with a sensor that generates work pulses. A respective control pulse is generated if a predetermined number of work pulses has been generated. A number of the work pulses is repeatedly detected in a respective time interval that corresponds to the predetermined time duration. The activation signals are each generated at each control pulse of a series, and the activation signals are offset forward in time relative to the respective control pulse corresponding to the number of work pulses that have been detected in the respective time interval. The activation signals are output to the processing device. | 02-28-2013 |
20130100194 | METHOD TO EXECUTE A PAUSE FUNCTION DURING PRINTING OPERATION IN AN INK PRINT APPARATUS - In a method to execute a pause function of an ink printing system wherein a printing substrate web is printed with a printing unit with print bars having print heads, a real value of a web tension of the printing substrate web is measured with a web tension sensor. In a printing operation the real value of the web pension is regulated to a predetermined desired operating value of the web tension. With triggering of the pause function, the web tension is further regulated by modifying the desired value of the web tension so that the printing substrate web assumes a position at the print heads after an end of the pause function that it had before a beginning of the pause function. After the end of the pause function, the real value of the web tension is regulated again to the desired operating value of the web tension. | 04-25-2013 |